X-Cell Tool And Mold, Inc. Acquisition Completes
X-Cell Tool and Mold acquisition expands SyBridge’s tooling capabilities to include highly complex precision tooling solutions necessary for the medical industry.
November 18, 2020
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
X-Cell Tool and Mold acquisition expands SyBridge’s tooling capabilities to include highly complex precision tooling solutions necessary for the medical industry.
The acquisition includes the STAR® total ankle arthroplasty system, a preferred technology worldwide because of its deep and leading clinical outcomes research, along with Silicone, Surface Replacement, and TACTYS® finger joint arthroplasty products, one of the world’s most comprehensive finger joint arthroplasty portfolios.
Medica Group acquired the company for an initial cash consideration of €16m (£14.5m) from private Irish healthcare group, Centric Health, on a cash-free and debt-free basis, and provides an update on current trading.
By joining the market leaders in virtual care and applied health signals, the combined company becomes the only consumer and healthcare provider partner to span a person’s entire health journey.
The company also announced further enhancement of its ENT portfolio with the recent acquisition of privately-held Ai Biomed Corp., maker of the PTeye™ parathyroid detection system.
In addition, Medtainer, which is a Florida corporation, changed its name to Advanced Container Technologies, Inc., effective October 3, 2020.